Although AFP is most commonlyemployed and currently available as serological markers of HCC for surveillance,diagnosis and patient outcome prediction28, 29, 30, HCC patientswithout AFP elevation (AFP < 20 ng/ml) are missed andsubsequently progress to late stage HCC before becoming clinically symptomatic anddetectable28, 30. The gene discussed is AFP; the disease is hepatocellular carcinoma.